Corporate News     15-Jul-19
Natco Pharma announces successful USFDA inspection of its facility in Chennai
Natco Pharma announced the successful completion of regulatory inspection from the U.S. Food and Drug Administration (FDA) for its Active Pharmaceutical Ingredient (API) facility in Chennai, India, conducted during the period 8 – 12 July 2019. The regulatory audit resulted in zero observations.
Previous News
  Sensex, Nifty end lower amid global cues; PSU bank shares slides; VIX rallies 3.86%
 ( Market Commentary - Quick Review 04-Sep-24   15:51 )
  Natco Pharma announces closure of buyback of shares
 ( Corporate News - 13-May-23   11:07 )
  Natco Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 26-Jun-23   13:05 )
  Natco Pharma update on legal complaint filed in US
 ( Corporate News - 18-Apr-24   09:30 )
  Natco Pharma Ltd spurts 1.64%, gains for third straight session
 ( Hot Pursuit - 29-May-23   13:05 )
  Barometers trade with modest losses; European mkt slides
 ( Market Commentary - Mid-Session 04-Sep-24   13:33 )
  Natco Pharma schedules AGM
 ( Corporate News - 12-Aug-24   16:48 )
  Indices extend gains; Nifty climbs above 17,500; PSU banks advance
 ( Market Commentary - Mid-Session 03-Mar-23   10:29 )
  Natco Pharma Ltd soars 2.4%, up for third straight session
 ( Hot Pursuit - 03-Mar-23   13:05 )
  Natco Pharma Ltd falls around 3%
 ( Hot Pursuit - 24-Feb-22   13:35 )
  Natco Pharma gains on buyback proposal
 ( Hot Pursuit - 03-Mar-23   09:29 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top